Sarcopenic obesity presents numerous risks to health and quality of life.
|
This webinar re-playing the popular session from the Obesity Medicine Conference 2021 provides a brief overview of FDA-approved anti-obesity medications (AOM’s).
|
The global COVID-19 pandemic has turned our patient’s lives and routines upside down.
|
Patients and Primary Care Clinicians face numerous difficulties in providing effective, affordable weight loss and maintenance programs.
|
During this webinar, Dr.
|
As the choices available for anti-obesity pharmacotherapy increase, clinicians are faced with options for addressing key clinical scenarios.
|
The OMA Obesity Algorithm has finished being revised for 2023 and is now available. In this webinar, Dr. Justin Tondt will highlight the changes from the previous edition.
|
Dr. Weber will present and discuss case examples that will increase familiarity with antiobesity medication indications, contraindications, side effect profiles, and medication interactions.
|
This session will review obesity as a chronic low-grade inflammatory state predisposing to chronic diseases including CAD/CVD and COVID-19 complications.
|
This webinar will provide an overview of challenging family dynamics identified in pediatric and adult weight management and bariatric surgery contexts, methods of assessment and screening for chal
|